• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC. MICOR LENS FRAGMENTATION SYSTEM; PHACOFRAGMENTATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC. MICOR LENS FRAGMENTATION SYSTEM; PHACOFRAGMENTATION SYSTEM Back to Search Results
Model Number FG-50621
Device Problem Use of Device Problem (1670)
Patient Problem Capsular Bag Tear (2639)
Event Date 10/02/2023
Event Type  Injury  
Event Description
A patient underwent cataract surgery in the right eye on (b)(6), 2023 where the micor lens fragmentation system (extractor and drive) was used to remove the cataractous lens fragments.During micor use, the patient's capsular bag was floppy and the high vacuum setting was used; the micor extractor caught the equator of the capsule which resulted in a small, circular posterior capsular tear.There was no vitreous loss and a 3-piece intraocular lens was implanted with optic capture.Preoperatively, the patient's best corrected visual acuity (bcva) in the operative eye was 20/40 +2, improving to 20/30 at the one-week postoperative visit.At this visit the patient was reported as healing appropriately and there has been no adverse impact on vision and no sequelae.
 
Manufacturer Narrative
The micor extractor was returned to the manufacturer and evaluated.The device was subjected to visual inspection and functional testing.There was no damage or device malfunction identified and the device met specifications and performed as intended.The micor extractor device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The device labeling identifies capsular rupture as an inherent safety risk.Manufacturer's reference #: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MICOR LENS FRAGMENTATION SYSTEM
Type of Device
PHACOFRAGMENTATION SYSTEM
Manufacturer (Section D)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC.
8740 technology way
reno NV 89521
Manufacturer (Section G)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
8740 technology way
reno NV 89521
Manufacturer Contact
andrew rybold
8740 technology way
reno 89521
7754731014
MDR Report Key18052505
MDR Text Key327125788
Report Number3012123033-2023-00006
Device Sequence Number1
Product Code HQC
UDI-Device Identifier00860000122368
UDI-Public00860000122368
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K222236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/05/2024
Device Model NumberFG-50621
Device Lot NumberFG23080901
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/06/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/02/2023
Initial Date FDA Received11/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/09/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-